Particle-Size-Dependent Delivery of Antitumoral MiRNA Using Targeted Mesoporous Silica Nanoparticles

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2020 Jun 6

PMID 32498278

Citations 14

Authors

Lisa Haddick

Wei Zhang

Soren Reinhard

Karin Moller

Hanna Engelke

Ernst Wagner

Thomas Bein

Affiliations

Soon will be listed here.

Abstract

Multifunctional core-shell mesoporous silica nanoparticles (MSN) were tailored in size ranging from 60 to 160 nm as delivery agents for antitumoral microRNA (miRNA). The positively charged particle core with a pore diameter of about 5 nm and a stellate pore morphology allowed for an internal, protective adsorption of the fragile miRNA cargo. A negatively charged particle surface enabled the association of a deliberately designed block copolymer with the MSN shell by charge-matching, simultaneously acting as a capping as well as endosomal release agent. Furthermore, the copolymer was functionalized with the peptide ligand GE11 targeting the epidermal growth factor receptor, EGFR. These multifunctional nanoparticles showed an enhanced uptake into EGFR-overexpressing T24 bladder cancer cells through receptor-mediated cellular internalization. A luciferase gene knock-down of up to 65% and additional antitumoral effects such as a decreased cell migration as well as changes in cell cycle were observed. We demonstrate that nanoparticles with a diameter of 160 nm show the fastest cellular internalization after a very short incubation time of 45 min and produce the highest level of gene knock-down.

Citing Articles

Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting.

Spada A, Gerber-Lemaire S Nanomaterials (Basel). 2025; 15(3).

PMID: 39940134 PMC: 11820047. DOI: 10.3390/nano15030158.

A Review of Nanotechnology in microRNA Detection and Drug Delivery.

Wang H Cells. 2024; 13(15.

PMID: 39120308 PMC: 11311607. DOI: 10.3390/cells13151277.

A Dual Concentration-Tailored Cytokine-Chemo Nanosystem to Alleviate Multidrug Resistance and Redirect Balance of Cancer Proliferation and Apoptosis.

Hsia Y, Sivasubramanian M, Chu C, Chuang Y, Lai Y, Lo L Int J Nanomedicine. 2023; 18:4253-4274.

PMID: 37534057 PMC: 10392912. DOI: 10.2147/IJN.S412932.

MicroRNAs-Based Theranostics against Anesthetic-Induced Neurotoxicity.

Minz R, Sharma P, Negi A, Kesari K Pharmaceutics. 2023; 15(7).

PMID: 37514018 PMC: 10385075. DOI: 10.3390/pharmaceutics15071833.

Current applications of nanomaterials in urinary system tumors.

Qian Z, Zhang Y, Yuan J, Gong S, Chen B Front Bioeng Biotechnol. 2023; 11:1111977.

PMID: 36890910 PMC: 9986335. DOI: 10.3389/fbioe.2023.1111977.

References

Nayak T, Krasteva L, Cai W . Multimodality imaging of RNA interference. Curr Med Chem. 2013; 20(29):3664-75. PMC: 3749287. DOI: 10.2174/0929867311320290012. View

Gao F, Botella P, Corma A, Blesa J, Dong L . Monodispersed mesoporous silica nanoparticles with very large pores for enhanced adsorption and release of DNA. J Phys Chem B. 2009; 113(6):1796-804. DOI: 10.1021/jp807956r. View

Chen F, Nayak T, Goel S, Valdovinos H, Hong H, Theuer C . In vivo tumor vasculature targeted PET/NIRF imaging with TRC105(Fab)-conjugated, dual-labeled mesoporous silica nanoparticles. Mol Pharm. 2014; 11(11):4007-14. PMC: 4218929. DOI: 10.1021/mp500306k. View

Moller K, Muller K, Engelke H, Brauchle C, Wagner E, Bein T . Highly efficient siRNA delivery from core-shell mesoporous silica nanoparticles with multifunctional polymer caps. Nanoscale. 2016; 8(7):4007-19. DOI: 10.1039/c5nr06246b. View

Wang M, Li X, Ma Y, Gu H . Endosomal escape kinetics of mesoporous silica-based system for efficient siRNA delivery. Int J Pharm. 2013; 448(1):51-7. DOI: 10.1016/j.ijpharm.2013.03.022. View

Gu J, Huang K, Zhu X, Li Y, Wei J, Zhao W . Sub-150 nm mesoporous silica nanoparticles with tunable pore sizes and well-ordered mesostructure for protein encapsulation. J Colloid Interface Sci. 2013; 407:236-42. DOI: 10.1016/j.jcis.2013.06.028. View

Gan Q, Dai D, Yuan Y, Qian J, Sha S, Shi J . Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery. Biomed Microdevices. 2011; 14(2):259-70. DOI: 10.1007/s10544-011-9604-9. View

Adams D, Gonzalez-Duarte A, ORiordan W, Yang C, Ueda M, Kristen A . Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis. N Engl J Med. 2018; 379(1):11-21. DOI: 10.1056/NEJMoa1716153. View

Korpal M, Lee E, Hu G, Kang Y . The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008; 283(22):14910-4. PMC: 3258899. DOI: 10.1074/jbc.C800074200. View

10.

Chen Y, Wang X, Liu T, Zhang D, Wang Y, Gu H . Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy. Int J Nanomedicine. 2015; 10:2579-94. PMC: 4386807. DOI: 10.2147/IJN.S78774. View

11.

Biscaglia F, Rajendran S, Conflitti P, Benna C, Sommaggio R, Litti L . Enhanced EGFR Targeting Activity of Plasmonic Nanostructures with Engineered GE11 Peptide. Adv Healthc Mater. 2017; 6(23). DOI: 10.1002/adhm.201700596. View

12.

Li Z, Zhao R, Wu X, Sun Y, Yao M, Li J . Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB J. 2005; 19(14):1978-85. DOI: 10.1096/fj.05-4058com. View

13.

Friedman R, Farh K, Burge C, Bartel D . Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2008; 19(1):92-105. PMC: 2612969. DOI: 10.1101/gr.082701.108. View

14.

Huang J, Bu L, Xie J, Chen K, Cheng Z, Li X . Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano. 2010; 4(12):7151-60. PMC: 3011031. DOI: 10.1021/nn101643u. View

15.

Hartono S, Gu W, Kleitz F, Liu J, He L, Middelberg A . Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery. ACS Nano. 2012; 6(3):2104-17. DOI: 10.1021/nn2039643. View

16.

Troiber C, Edinger D, Kos P, Schreiner L, Klager R, Herrmann A . Stabilizing effect of tyrosine trimers on pDNA and siRNA polyplexes. Biomaterials. 2012; 34(5):1624-33. DOI: 10.1016/j.biomaterials.2012.11.021. View

17.

Varela J, G Bexiga M, Aberg C, Simpson J, Dawson K . Quantifying size-dependent interactions between fluorescently labeled polystyrene nanoparticles and mammalian cells. J Nanobiotechnology. 2012; 10:39. PMC: 3492040. DOI: 10.1186/1477-3155-10-39. View

18.

Zhu J, Tang J, Zhao L, Zhou X, Wang Y, Yu C . Ultrasmall, well-dispersed, hollow siliceous spheres with enhanced endocytosis properties. Small. 2009; 6(2):276-82. DOI: 10.1002/smll.200901631. View

19.

Huang X, Teng X, Chen D, Tang F, He J . The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials. 2009; 31(3):438-48. DOI: 10.1016/j.biomaterials.2009.09.060. View

20.

Lu F, Wu S, Hung Y, Mou C . Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small. 2009; 5(12):1408-13. DOI: 10.1002/smll.200900005. View